Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Hot Flashes|Breast Cancer
Interventions: DRUG: 0.8 mg RCN3028|DRUG: Placebo
Sponsor: Yung Shin Pharm. Ind. Co., Ltd.